BIOTRONIK released its Lumax 740 ICDs (implantable cardiac defibrillators) and CRT-Ds (cardiac resynchronization therapy defibrillators) in the EU, the world’s only line of CRT-Ds and ICDs approved for use with magnetic resonance imaging.
The new Lumax 740 series is part of of BIOTRONIK’s technologically advanced product portfolio of tachyarrhythmia therapy devices with the innovative ProMRI® technology.
A portfolio of single- and dual-chamber ICDs as well as a CRT-D device, complemented by 16 leads enable physicians to provide patients access to MRI while having the freedom to select the optimal ICD system according to the patients’ indication.
Furthermore, Lumax 740 provides unique therapy options such as the world’s only single-chamber ICD with complete atrial diagnostics—the Lumax 740 VR-T DX.
The new sensor analyses changes in impedance during the cycle of the heart and is being evaluated in clinical studies. This new feature aims to enhance therapy for heart failure patients in the future.
Innovative solutions for heart failure patients are integrated in the Lumax 740 HF-T device that enables enhanced CRT effectiveness and includes a new research feature: the Intracardiac Impedance (ICI) measurement.
Product page: Lumax 740…